VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
WSTWest Pharmaceutical Services, Inc.
$328.03$23.6B
Research
OverviewAnalysis
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksWSTPrice Target
WST logo

West Pharmaceutical Services, Inc. (WST) Price Target Analysis

Updated Jun 18, 2026
Analyst Rating: Buy
Based on 15 analysts

0.9% Below Target

WST trades 0.9% below Wall Street's consensus target of $330.83.

Current Price$328.03
Average Target$330.83
Target
Current
Low$295.00
Median$317.50
High$400.00

Analyst Target Range

Forward P/E38.1x
(Growth Premium)
PEG Ratio4.60
(Expensive)
Implied Growth+14.9%
(Moderate)
Analyst Spread31.7%
(Moderate)

Price Forecast (1 Year)

Last 12 months price action with 12-month analyst target path

Current$328.03
Consensus$330.83
High$400.00
Low$295.00

Consensus Scenario Assumptions

The base valuation assumes WST achieves its forward estimates and maintains a stable P/E multiple of 38.1x. This scenario reflects the blended consensus of 15 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.

Analyst Ratings Distribution

Breakdown of 15 published analyst recommendations for WST

11/15 analysts are bullish
+33
BearishBullish
Weighted analyst sentiment score based on 15 ratings
ConsensusBuy
Coverage15 Analysts
Net Score+33
Bull / Bear73% / 7%
Strong Buy00%
Buy1173%
Hold320%
Sell17%
Strong Sell00%
Strong Buy
00%
Buy
1173%
Hold
320%
Sell
17%
Strong Sell
00%
Recommendation Mix73% Buy · 20% Hold · 7% Sell
Buy (11)Hold (3)Sell (1)

WST Price Target Analysis

Updated June 22, 2026

As of June 22, 2026, West Pharmaceutical Services, Inc. (WST) has a Wall Street consensus price target of $330.83, based on estimates from 15 covering analysts. With the stock currently trading at $328.03, this represents a potential upside of +0.9%. The company has a market capitalization of $23.64B.

Analyst price targets range from a low of $295.00 to a high of $400.00, representing a 32% spread in expectations. The median target of $317.50 aligns closely with the consensus average.

The current analyst consensus rating is Buy, with 11 analysts rating the stock as a Buy or Strong Buy,3 rating it Hold, and 1 rating it Sell or Strong Sell. This overwhelmingly bullish sentiment suggests analysts see significant catalysts for upside ahead.

From a valuation perspective, WST trades at a trailing P/E of 48.2x and forward P/E of 38.1x. The forward PEG ratio of 4.60 reflects a premium valuation. Analysts expect EPS to grow +14.9% over the next year.

Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $403.63, with bear and bull scenarios of $254.29 and $531.82 respectively. Model confidence stands at 55/100, reflecting moderate uncertainty in projections.

Investment Context: Price targets represent analyst expectations for the next 12 months and should be considered alongside your own research. Targets are based on analysts' assumptions about earnings growth, margins, and market conditions which may change. For sector-specific context, view other Healthcare stocks.

Analyst Sentiment Comparison

Industry Peer Analysis
Avg Peer Upside
+15.2%
Industry Consensus
Avg Forward P/E
16.4x
(Fair)
Peers with Coverage
10 / 10
Active Analyst Tracking
CompanyMarket CapPriceTargetUpside PotentialRatingFwd P/EAnalysts
ATR logo
ATRAptarGroup, Inc.
$7.7B$120.32$188.00
+56.3%
Buy21.8x18
GTLS logo
GTLSChart Industries, Inc.
$10.0B$207.99$193.81
-6.8%
Buy29.9x37
AVTR logo
AVTRAvantor, Inc.
$6.5B$9.58$9.17
-4.3%
Hold12.2x26
AMCR logo
AMCRAmcor plc
$19.0B$41.08$47.75
+16.2%
Buy10.3x13
SEE logo
SEESealed Air Corporation
$6.2B$42.15$49.92
+18.4%
Buy12.4x27
PFE logo
PFEPfizer Inc.
$143.5B$25.22$26.75
+6.1%
Hold8.5x39
JNJ logo
JNJJohnson & Johnson
$550.4B$228.39$251.55
+10.1%
Buy19.7x40
MRK logo
MRKMerck & Co., Inc.
$281.2B$113.87$131.58
+15.6%
Buy22.2x37
ABBV logo
ABBVAbbVie Inc.
$383.2B$216.63$256.92
+18.6%
Buy15.2x41
BDX logo
BDXBecton, Dickinson and Company
$52.2B$143.98$174.81
+21.4%
Hold11.4x34

WST — Frequently Asked Questions

Quick answers to the most common questions about buying WST stock.

What is the WST stock price target for 2026?

The consensus price target for WST is $330.83, close to the current price of $328.03 (0.9% implied move). Based on 15 analyst estimates, the stock appears fairly valued near current levels.

Is WST a buy, sell, or hold?

WST has a consensus rating of "Buy" based on 15 Wall Street analysts. The rating breakdown is predominantly bullish, with 11 Buy/Strong Buy ratings. The consensus 12-month price target of $330.83 implies 0.9% upside from current levels.

Is WST stock overvalued or undervalued?

At a forward P/E of 38.0912x, WST trades at a premium valuation. The consensus price target of $330.83 (0.9% upside) suggests analysts may view current valuations as stretched.

How high can WST stock go?

The most bullish Wall Street analyst has a price target of $400 for WST, while the most conservative target is $295. The consensus of $330.83 represents the median expectation. Our quantitative valuation model projects a bull case target of $532 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.

How many analysts cover WST stock?

WST is well covered by analysts, with 15 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 11 have Buy ratings, 3 recommend Hold, and 1 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.

What is the WST stock forecast?

The 12-month WST stock forecast based on 15 Wall Street analysts shows a consensus price target of $330.83, with estimates ranging from $295 (bear case) to $400 (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $404, with bear/bull scenarios of $254/$532.

What is WST's fair value based on fundamentals?

Our quantitative valuation model calculates WST's fair value at $404 (base case), with a bear case of $254 and bull case of $532. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 55/100.

What is WST's forward P/E ratio?

WST trades at a forward P/E ratio of 38.1x based on next-twelve-months earnings estimates compared to a trailing P/E of 48.2x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.

Should I buy WST stock?

WST appears fairly valued according to analysts, with a "Buy" rating and minimal upside to the $330.83 target. Consider your investment thesis and risk tolerance. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.

Why do WST price targets vary so much?

WST analyst price targets range from $295 to $400, a 32% moderate spread showing some variance in outlooks. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $330.83 consensus represents the middle ground. Our model's $254-$532 range provides an independent fundamental perspective.

Consensus-Based Analysis Tools

Full Stock Analysis

Deep dive into WST consensus models and risk factors.

View Analysis

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare